Related Experiment Video
Updated: Aug 7, 2026

08:08
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
Published on: October 16, 2013
[IGF-I sensitivity in small for gestational age children]
Rossana Román R1, Germán Iñíguez V, Teresa Salazar C
1Instituto de Investigaciones Materno Infantil, Universidad de Chile, Santiago, Chile.
Summary
Small for gestational age (SGA) children lacking catch-up growth (CUG) may have reduced insulin-like growth factor 1 (IGF-I) sensitivity. This study found decreased pituitary sensitivity to IGF-I in some SGA children without CUG.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Physiology
- Insulin-like Growth Factor Signaling
Context:
- Small for gestational age (SGA) is a condition where infants are born smaller than expected based on gestational age.
- Catch-up growth (CUG) is a period of accelerated growth that may occur after a period of slowed growth.
- Reduced sensitivity to insulin-like growth factor 1 (IGF-I) has been hypothesized as a cause for the lack of CUG in SGA children.
Purpose:
- To investigate the sensitivity to IGF-I in prepubertal SGA children.
- To measure nocturnal growth hormone (GH) profiles before and after IGF-I administration to assess pituitary response.
Summary:
- Thirty-four prepubertal SGA children (4-11 years) were studied, with 23 exhibiting CUG and 11 not.
- Nocturnal GH levels were measured at baseline and after administration of the IGF-I + IGFBP-3 complex (Somatokine).
- While GH levels decreased in all SGA children post-Somatokine, 3 of 11 SGA children without CUG showed an increase in GH AUC, suggesting potentially decreased pituitary sensitivity to IGF-I in this subgroup.
Impact:
- Findings suggest that impaired pituitary sensitivity to IGF-I may contribute to the failure of catch-up growth in a subset of SGA children.
- This research highlights a potential mechanism underlying growth disturbances in SGA individuals.
- Further investigation into IGF-I signaling pathways could inform therapeutic strategies for SGA children.

